mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.52 |
0.09 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.09 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.09 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.09 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.09 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.09 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.09 |